跳至: [中文]   [數字0-9]   [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ] 請輸入前幾個字:

顯示項目2881-2890 / 12927. (共1293頁) << < 284 285 286 287 288 289 290 291 292 293 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2018-01	Criterion-referenced values of grip strength and usual gait speed using instrumental activities of daily living disability as the criterion	Journal of Geriatric Physical Therapy. 2018 Jan;41(1):14-19.
2017-10-02	Critical assessment of metagenome interpretation-A benchmark of metagenomics software	Nature Methods. 2017 Oct 02;14(11):1063-1071.
2022-09-12	A critical overview of current progress for COVID-19: Development of vaccines, antiviral drugs, and therapeutic antibodies	Journal of Biomedical Science. 2022 Sep 12;29:Article number 68.
2008-08	Critical role of p53 in histone deacetylase inhibitor-induced Epstein-Barr virus Zta expression	Journal of Virology. 2008 Aug;82(15):7745-7751.
1997-10	Cross regulation by IL-10 and 1L-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients	Chest. 1997 Oct;112(4):960-966.
1997-02	Cross sectional study of use of alternative medicines in Chinese cancer patients	Japanese Journal of Clinical Oncology. 1997 Feb;27(1):37-41.
2012-06-12	Cross-linked oxidated hyaluronic acid for use as a vitreous substitute	US8197849B2/2012-06-12
2014-08-04	Cross-linked oxidated hyaluronic acid for use as a vitreous substitute	KR10-1428898/2014-08-04
2014-04-17	Cross-linked oxidated hyaluronic acid for use as a vitreous substitute	AU2011215775/2014-04-17
2015-04-08	Cross-linked oxidated hyaluronic acid for use as a vitreous substitute	EP2534200/2015-04-08

顯示項目2881-2890 / 12927. (共1293頁) << < 284 285 286 287 288 289 290 291 292 293 > >> 每頁顯示[10|25|50]項目